Show
Sort by
-
- Journal Article
- A1
- open access
Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib : final 6-year results from a Belgian registry
-
- Journal Article
- A1
- open access
A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages
-
Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies
-
AXL-specific single domain antibodies show diagnostic potential and antitumor activity in acute myeloid leukemia
-
Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT) : a prospective study from the Belgian Hematology Society (BHS)
-
Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature
-
- Journal Article
- A1
- open access
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry
-
Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres
-
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis
-
- Journal Article
- A1
- open access
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society